Literature DB >> 10481965

Penetration of a single infusion of ampicillin and sulbactam into prostatic tissue during transurethral prostatectomy.

T Klotz1, M Braun, A Bin Saleh, M Orlovski, U Engelmann.   

Abstract

Antibiotic prophylaxis is recommended in endoscopic urological operations to diminish the rate of intraoperative septic complications and relevant urogenital infections. The objective of the study was to determine the tissue concentrations of preoperatively administered ampicillin and sulbactam in the human prostate in patients undergoing transurethral resection (TUR-P) for benign prostatic hyperplasia (BPH). In 19 patients (mean age 68.7 years) the serum and tissue concentrations of ampicillin and sulbactam were determined. For all patients the dosage was administered as a single infusion over 15 min at a 2:1 ratio, i.e. 2 g ampicillin and 1 g sulbactam. The serum and prostatic tissue samples were taken 15 to 55 min (mean 29.5 min) after infusion. Of transurethral resected prostatic chips 3 g were immediately collected after resection and stored at -70 degrees C. Ampicillin was determined by bioassay and sulbactam was determined by gas chromatography/mass spectrometry. Tissue concentrations of ampicillin ranged from 0.42 to 548.33 mg/kg (median 47 mg/kg). Tissue concentrations of sulbactam ranged from 0.15 to 249.74 mg/kg (median 19 mg/kg). Six (32%) of 19 patients showed a tissue concentration of ampicillin <4 mg/kg (MIC90), respectively 5 (26%) patients of sulbactam <8 mg/kg. The mean serum concentrations at tissue sampling time were 118.8+/-48.9 mg/l respectively 32.2+/-12.2 mg/l. There exists a high variability of intraprostatic concentrations of ampicillin and sulbactam after single infusion in patients with BPH. In a relevant part of patients both compounds do not exceed the minimal inhibitory concentrations (MIC) of important bacterial pathogens. A single shot infusion of 3 g ampicillin/sulbactam for intraoperative antibiotic prophylaxis is not sufficient in patients undergoing TUR-P. It seems that the prostate cannot be compared to other tissues in view of penetration of ampicillin/sulbactam.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10481965     DOI: 10.1023/a:1007128825726

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  25 in total

1.  Characterization and localization of nitric oxide synthase in the human prostate.

Authors:  A L Burnett; M P Maguire; S L Chamness; D D Ricker; M Takeda; H Lepor; T S Chang
Journal:  Urology       Date:  1995-03       Impact factor: 2.649

2.  Concentrations of ceftriaxone (1,000 milligrams intravenously) in abdominal tissues during open prostatectomy.

Authors:  C Martin; X Viviand; A Cottin; V Savelli; C Brousse; E Ragni; C Richaud; M N Mallet
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

3.  [Ampicillin pharmacokinetics in prostatic adenoma patients].

Authors:  V P Iakovlev; L Z Skala; R A Slobodskoĭ; A G Nekhorosheva; L A Lur'e
Journal:  Antibiot Med Biotekhnol       Date:  1987-07

4.  Penetration of ampicillin and sulbactam into human epididymis and testis.

Authors:  T Klotz; M Braun; A Wildfeuer; U Engelmann
Journal:  Infection       Date:  1996 Sep-Oct       Impact factor: 3.553

5.  Distribution of nitric oxide synthase implies a regulation of circulation, smooth muscle tone, and secretory function in the human prostate by nitric oxide.

Authors:  W Bloch; T Klotz; C Loch; G Schmidt; U Engelmann; K Addicks
Journal:  Prostate       Date:  1997-09-15       Impact factor: 4.104

6.  Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective randomized trial of cefuroxime versus piperacillin/tazobactam.

Authors:  S F Brewster; A P MacGowan; J C Gingell
Journal:  Br J Urol       Date:  1995-09

7.  Pharmacokinetics of ampicillin and sulbactam in patients undergoing heart surgery.

Authors:  A Wildfeuer; V Müller; M Springsklee; H G Sonntag
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

8.  Pharmacokinetics of sulbactam and ampicillin intravenously applied in combination to healthy volunteers and patients. Determination of the ratio of the two drugs in serum and in various tissues.

Authors:  A Wildfeuer; U Schwiersch; K Engel; E von Castell; A Schilling; J Potempa; H Lenders
Journal:  Arzneimittelforschung       Date:  1988-11

9.  Pharmacokinetics of sulbactam in humans.

Authors:  G Foulds; J P Stankewich; D C Marshall; M M O'Brien; S L Hayes; D J Weidler; F G McMahon
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

Review 10.  [Pharmacokinetic criteria of the choice of antibiotic for antibiotic prophylaxis in surgery].

Authors:  R Garraffo; D Pharm
Journal:  Ann Fr Anesth Reanim       Date:  1994
View more
  1 in total

1.  Catheter-associated bacterial flora in patients with benign prostatic hyperplasia: shift in antimicrobial susceptibility pattern.

Authors:  Bartosz A Dybowski; Piotr Zapała; Ewa Bres-Niewada; Łukasz Zapała; Nina Miązek-Zapała; Sławomir Poletajew; Grażyna Młynarczyk; Piotr Radziszewski
Journal:  BMC Infect Dis       Date:  2018-11-20       Impact factor: 3.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.